-
November
8,
2011
Oceana Therapeutics Announces Definitive Agreement to be Acquired by Salix Pharmaceuticals
-
September
6,
2011
Oceana Therapeutics Announces U.S. Launch of Solesta®, The Only Nonsurgical FDA Approved Treatment for Patients Who Fail Conservative Therapy for Fecal (Bowel) Incontinence
-
August
12,
2011
Oceana Therapeutics Announces David S. Tierney, MD Named to the 2011 PharmaVOICE 100 Most Inspiring People in the Life Sciences Industry
-
June
28,
2011
Oceana Therapeutics Announces John T. Spitznagel and David S. Tierney, MD Named Ernst & Young Entrepreneur Of The Year® 2011 Award Winners
-
May
31,
2011
FDA Approves Solesta®; Novel Specialty Therapeutic Addresses Large Treatment Void for Patients with Life-Altering Fecal (Bowel) Incontinence
-
May
17,
2011
Oceana Therapeutics Announces John T. Spitznagel and David S. Tierney, MD Named 2011 Entrepreneur Of The Year® Award Finalists
-
May
16,
2011
Oceana Therapeutics Announces Strategic Alliance Providing Dr. Reddy’s Laboratories Rights to Deflux® in India
-
May
13,
2011
Oceana Therapeutics to Present Posters on Solesta® for Fecal (Bowel) Incontinence at ASCRS Annual Meeting
-
April
7,
2011
Oceana Therapeutics Gets FDA Approvable Letter for Solesta®, a Significant Treatment Option for Fecal (Bowel) Incontinence
-
March
18,
2011
Results Published in The Lancet Demonstrate Fecal Incontinence Symptoms Improve with Bulking Agent Injection
© Oceana Therapeutics, Inc.